Genmab
Differentiated human antibody therapeutics for the treatment of cancer. Learn more
Launch date
Employees
Market cap
$16.7b
Enterprise valuation
$14.5b (Public information from Sep 2024)
Share price
DKK2491 GMAB
Company register number 21023884
Copenhagen Capital Region of Denmark (HQ)
Authorizing premium user...